» Articles » PMID: 32391355

Cancer Radiotherapy: Understanding the Price of Tumor Eradication

Overview
Specialty Cell Biology
Date 2020 May 12
PMID 32391355
Citations 12
Authors
Affiliations
Soon will be listed here.
Citing Articles

Radioresistance in Hepatocellular Carcinoma: Biological Bases and Therapeutic Implications.

Wu J, Zhao X, Ren B, Duan X, Sun J Int J Mol Sci. 2025; 26(5).

PMID: 40076465 PMC: 11899467. DOI: 10.3390/ijms26051839.


Myriad factors and pathways influencing tumor radiotherapy resistance.

Mi L, Zhang H Open Life Sci. 2024; 19(1):20220992.

PMID: 39655194 PMC: 11627069. DOI: 10.1515/biol-2022-0992.


Non-coding RNAs modulation in breast cancer radioresponse: mechanisms and therapeutic implications.

Moqadami A, Ghafari S, Khalaj-Kondori M Strahlenther Onkol. 2024; .

PMID: 39545960 DOI: 10.1007/s00066-024-02317-4.


The Potential of Human Pulmonary Mesenchymal Stem Cells as Vectors for Radiosensitizing Metallic Nanoparticles: An In Vitro Study.

Arcambal A, Septembre-Malaterre A, Pesnel S, Morel A, Gasque P, Begue M Cancers (Basel). 2024; 16(18).

PMID: 39335210 PMC: 11430180. DOI: 10.3390/cancers16183239.


The potential of vascular normalization for sensitization to radiotherapy.

Guo Z, Lei L, Zhang Z, Du M, Chen Z Heliyon. 2024; 10(12):e32598.

PMID: 38952362 PMC: 11215263. DOI: 10.1016/j.heliyon.2024.e32598.


References
1.
Majer M, Knezevic Z, Saveta M . Current trends in estimating risk of cancer from exposure to low doses of ionising radiation. Arh Hig Rada Toksikol. 2014; 65(3):251-7. DOI: 10.2478/10004-1254-65-2014-2425. View

2.
Paulino A, Constine L, Rubin P, Williams J . Normal tissue development, homeostasis, senescence, and the sensitivity to radiation injury across the age spectrum. Semin Radiat Oncol. 2009; 20(1):12-20. DOI: 10.1016/j.semradonc.2009.08.003. View

3.
Lobachevsky P, Ivashkevich A, Forrester H, Stevenson A, Hall C, Sprung C . Assessment and Implications of Scattered Microbeam and Broadbeam Synchrotron Radiation for Bystander Effect Studies. Radiat Res. 2015; 184(6):650-9. DOI: 10.1667/RR13720.1. View

4.
Travis L . The epidemiology of second primary cancers. Cancer Epidemiol Biomarkers Prev. 2006; 15(11):2020-6. DOI: 10.1158/1055-9965.EPI-06-0414. View

5.
Durante M, Brauer-Krisch E, Hill M . Faster and safer? FLASH ultra-high dose rate in radiotherapy. Br J Radiol. 2017; 91(1082):20170628. PMC: 5965780. DOI: 10.1259/bjr.20170628. View